NO996178D0 - 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister - Google Patents

4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister

Info

Publication number: NO996178D0
Authority: NO; Norway
Prior art keywords: aminopyrrole; neuropeptide; pyrimidines; receptor antagonists; antagonists
Prior art date: 1997-08-05

Application number

NO996178A

Other languages

English (en)

Other versions

NO996178L (no

Inventor

Robert Lee Dow

Marlys Hammond

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-05

Filing date

1999-12-14

Publication date

1999-12-14

1999-12-14 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-12-14 Publication of NO996178D0 publication Critical patent/NO996178D0/no

2000-02-14 Publication of NO996178L publication Critical patent/NO996178L/no

Links

PLSDWRYNZIVQKX-BGKYVOMCSA-N (3S)-3-amino-4-[[(2S)-1-[[2-[[(2S)-1-[[2-[[(2S)-5-amino-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-3-methylsulfanylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CC4=CNC=N4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)N PLSDWRYNZIVQKX-BGKYVOMCSA-N 0.000 title 1
WAUGGYPDCQZJKK-UHFFFAOYSA-N 1h-pyrrol-3-amine Chemical compound NC=1C=CNC=1 WAUGGYPDCQZJKK-UHFFFAOYSA-N 0.000 title 1
102100024304 Protachykinin-1 Human genes 0.000 title 1
150000003230 pyrimidines Chemical class 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
108010073085 tachykinin neuropeptide gamma Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO996178A 1997-08-05 1999-12-14 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister NO996178L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5473497P	1997-08-05	1997-08-05
PCT/IB1998/001053 WO1999007703A1 (en)	1997-08-05	1998-07-10	4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS

Publications (2)

Publication Number	Publication Date
NO996178D0 true NO996178D0 (no)	1999-12-14
NO996178L NO996178L (no)	2000-02-14

Family

ID=21993163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996178A NO996178L (no)	1997-08-05	1999-12-14	4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister

Country Status (32)

Country	Link
US (1)	US6187778B1 (no)
EP (1)	EP1003744B1 (no)
JP (1)	JP3711238B2 (no)
KR (1)	KR20010022583A (no)
CN (1)	CN1264381A (no)
AP (1)	AP9801312A0 (no)
AT (1)	ATE296825T1 (no)
AU (1)	AU7927498A (no)
BG (1)	BG104107A (no)
BR (1)	BR9811844A (no)
CA (1)	CA2293621C (no)
CO (1)	CO4960634A1 (no)
DE (1)	DE69830409T2 (no)
EA (1)	EA200000098A1 (no)
ES (1)	ES2241146T3 (no)
GT (1)	GT199800114A (no)
HR (1)	HRP980434A2 (no)
HU (1)	HUP0002956A3 (no)
ID (1)	ID24300A (no)
IL (1)	IL133430A0 (no)
IS (1)	IS5294A (no)
MA (1)	MA24629A1 (no)
NO (1)	NO996178L (no)
OA (1)	OA11277A (no)
PA (1)	PA8456601A1 (no)
PE (1)	PE106199A1 (no)
PL (1)	PL338575A1 (no)
SA (1)	SA98190435A (no)
TN (1)	TNSN98148A1 (no)
TR (1)	TR200000333T2 (no)
WO (1)	WO1999007703A1 (no)
ZA (1)	ZA986968B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
CA2379633C (en) *	1999-09-30	2006-06-20	Neurogen Corporation	Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
SK288019B6 (sk) *	1999-12-24	2012-11-05	Aventis Pharma Limited	Azaindoles derivatives, their use and pharmaceutical composition containing thereof
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
GEP20105024B (en)	2004-06-02	2010-06-25	Takeda Pharmaceuticals Co	Fused heterocyclic compound
JP2008503470A (ja)	2004-06-17	2008-02-07	ワイス	ゴナドトロピン放出ホルモン受容体アンタゴニストの製造法
AU2005264996A1 (en)	2004-06-17	2006-01-26	Wyeth	Gonadotropin releasing hormone receptor antagonists
TW200615268A (en) *	2004-08-02	2006-05-16	Osi Pharm Inc	Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
MY179032A (en)	2004-10-25	2020-10-26	Cancer Research Tech Ltd	Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
EP1861387B1 (en) *	2005-01-28	2014-04-16	Daewoong Pharmaceutical Co., Ltd.	Benzimidazole derivatives and pharmaceutical compositions thereof
KR20060087386A (ko) *	2005-01-28	2006-08-02	주식회사 대웅제약	신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
US7582634B2 (en)	2005-02-18	2009-09-01	Wyeth	7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en)	2005-02-18	2009-05-26	Wyeth	4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en)	2005-02-18	2009-05-19	Wyeth	Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US20090213731A1 (en) *	2005-04-15	2009-08-27	Regenertech Pty Limited	Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration
US7531542B2 (en)	2005-05-18	2009-05-12	Wyeth	Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en)	2005-05-26	2009-09-01	Wyeth	Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
US7994331B2 (en) *	2005-07-13	2011-08-09	Msd K.K.	Heterocycle-substituted benzimidazole derivative
AR055669A1 (es) *	2005-10-03	2007-08-29	Astrazeneca Ab	Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
AR057525A1 (es) *	2005-10-03	2007-12-05	Astrazeneca Ab	Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion
WO2007067537A1 (en) *	2005-12-07	2007-06-14	Osi Pharmaceuticals, Inc.	Pyrrolopyridine kinase inhibiting compounds
US8088761B2 (en) *	2005-12-22	2012-01-03	Cancer Research Technology Limited	Enzyme inhibitors
ES2374455T3 (es)	2006-02-17	2012-02-16	Pfizer Limited	Derivados de 3-deazapurinza como moduladores de tlr7.
EP3421471B1 (en)	2006-04-25	2021-05-26	Astex Therapeutics Limited	Purine and deazapurine derivatives as pharmaceutical compounds
KR101134239B1 (ko)	2006-07-11	2012-04-10	주식회사 대웅제약	신규한 바이아릴 벤조이미다졸 유도체 및 이를 함유하는 약학 조성물
MY157033A (en) *	2006-07-11	2016-04-15	Dae Woong Pharma	Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
CL2007002617A1 (es)	2006-09-11	2008-05-16	Sanofi Aventis	Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008121064A1 (en) *	2007-03-30	2008-10-09	Astrazeneca Ab	New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
DE102007027800A1 (de)	2007-06-16	2008-12-18	Bayer Healthcare Ag	Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
ES2522365T3 (es)	2007-10-11	2014-11-14	Astrazeneca Ab	Derivados de pirrolo [2,3-D] pirimidina como inhibidores de proteína quinasas B
EP2247596A2 (en)	2008-01-11	2010-11-10	Natco Pharma Limited	Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
US9402847B2 (en)	2011-04-01	2016-08-02	Astrazeneca Ab	Combinations comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
DK2785349T4 (da)	2011-11-30	2023-01-09	Astrazeneca Ab	Kombinationsbehandling af cancer
AU2013204533B2 (en)	2012-04-17	2017-02-02	Astrazeneca Ab	Crystalline forms
US11053241B2 (en) *	2018-11-30	2021-07-06	Nimbus Lakshmi, Inc.	TYK2 inhibitors and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3274213A (en)	1961-09-05	1966-09-20	Upjohn Co	Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
DE2818676A1 (de) *	1978-04-27	1979-11-08	Troponwerke Gmbh & Co Kg	Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9022644D0 (en) *	1990-10-18	1990-11-28	Ici Plc	Heterocyclic compounds
US5877178A (en) *	1991-04-08	1999-03-02	Duquesne University Of The Holy Ghost	Pyrimidine derivatives and methods of making and using these derivatives
US5235053A (en) *	1992-06-22	1993-08-10	Eli Lilly And Company	Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5284971A (en)	1992-07-16	1994-02-08	Syntex (U.S.A.) Inc.	4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
EP0580550B1 (en)	1992-07-21	1997-10-22	Novartis AG	Oxamic acid derivatives as hypocholesteremic agents
EP0682027B1 (de) *	1994-05-03	1997-10-15	Novartis AG	Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
WO1996010028A1 (en) *	1994-09-29	1996-04-04	Novartis Ag	PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
US6562862B1 (en)	1994-10-20	2003-05-13	Eli Lilly And Company	Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
HUT78089A (hu)	1994-11-07	1999-08-30	Pfizer Inc.	Neuropeptid Y1 receptorokhoz szelektíven kötődő szubsztituált piperazin-származékok
US5644057A (en) *	1995-05-12	1997-07-01	Neurogen Corporation	Deazapurine derivatives; a new class of CRF1 specific ligands
EP0759441A3 (en)	1995-06-30	1999-06-30	Eli Lilly And Company	Methods of treating neuropeptide Y-associated conditions
JP2000501107A (ja) *	1996-01-09	2000-02-02	イーライ・リリー・アンド・カンパニー	ベンズイミダゾリル神経ペプチドｙ受容体アンタゴニスト

1998
- 1998-07-10 CN CN98807398A patent/CN1264381A/zh active Pending
- 1998-07-10 EA EA200000098A patent/EA200000098A1/ru unknown
- 1998-07-10 EP EP98929573A patent/EP1003744B1/en not_active Expired - Lifetime
- 1998-07-10 BR BR9811844-7A patent/BR9811844A/pt not_active Application Discontinuation
- 1998-07-10 AU AU79274/98A patent/AU7927498A/en not_active Abandoned
- 1998-07-10 US US09/380,901 patent/US6187778B1/en not_active Expired - Fee Related
- 1998-07-10 IL IL13343098A patent/IL133430A0/xx unknown
- 1998-07-10 CA CA002293621A patent/CA2293621C/en not_active Expired - Fee Related
- 1998-07-10 TR TR2000/00333T patent/TR200000333T2/xx unknown
- 1998-07-10 AT AT98929573T patent/ATE296825T1/de not_active IP Right Cessation
- 1998-07-10 HU HU0002956A patent/HUP0002956A3/hu unknown
- 1998-07-10 WO PCT/IB1998/001053 patent/WO1999007703A1/en not_active Ceased
- 1998-07-10 DE DE69830409T patent/DE69830409T2/de not_active Expired - Fee Related
- 1998-07-10 ES ES98929573T patent/ES2241146T3/es not_active Expired - Lifetime
- 1998-07-10 KR KR1020007001174A patent/KR20010022583A/ko not_active Ceased
- 1998-07-10 PL PL98338575A patent/PL338575A1/xx unknown
- 1998-07-10 JP JP2000506207A patent/JP3711238B2/ja not_active Expired - Fee Related
- 1998-07-10 ID IDW20000021A patent/ID24300A/id unknown
- 1998-07-27 GT GT199800114A patent/GT199800114A/es unknown
- 1998-07-30 PE PE1998000678A patent/PE106199A1/es not_active Application Discontinuation
- 1998-07-30 AP APAP/P/1998/001312A patent/AP9801312A0/en unknown
- 1998-08-03 PA PA19988456601A patent/PA8456601A1/es unknown
- 1998-08-04 MA MA25203A patent/MA24629A1/fr unknown
- 1998-08-04 HR HR60/054,734A patent/HRP980434A2/hr not_active Application Discontinuation
- 1998-08-04 ZA ZA9806968A patent/ZA986968B/xx unknown
- 1998-08-04 TN TNTNSN98148A patent/TNSN98148A1/fr unknown
- 1998-08-05 CO CO98044925A patent/CO4960634A1/es unknown
- 1998-08-19 SA SA98190435A patent/SA98190435A/ar unknown
1999
- 1999-12-10 IS IS5294A patent/IS5294A/is unknown
- 1999-12-14 NO NO996178A patent/NO996178L/no not_active Application Discontinuation
2000
- 2000-01-14 OA OA1200000007A patent/OA11277A/en unknown
- 2000-01-26 BG BG104107A patent/BG104107A/bg unknown

Also Published As

Publication number	Publication date
CA2293621C (en)	2003-12-30
EP1003744A1 (en)	2000-05-31
NO996178L (no)	2000-02-14
IL133430A0 (en)	2001-04-30
ID24300A (id)	2000-07-13
PL338575A1 (en)	2000-11-06
DE69830409T2 (de)	2006-01-26
CO4960634A1 (es)	2000-09-25
ES2241146T3 (es)	2005-10-16
DE69830409D1 (de)	2005-07-07
HRP980434A2 (en)	1999-04-30
OA11277A (en)	2003-07-29
BR9811844A (pt)	2000-08-08
TNSN98148A1 (fr)	2005-03-15
CA2293621A1 (en)	1999-02-18
ZA986968B (en)	2000-02-04
IS5294A (is)	1999-12-10
BG104107A (bg)	2000-08-31
HUP0002956A2 (hu)	2001-08-28
US6187778B1 (en)	2001-02-13
HUP0002956A3 (en)	2002-01-28
MA24629A1 (fr)	1999-04-01
JP3711238B2 (ja)	2005-11-02
WO1999007703A1 (en)	1999-02-18
CN1264381A (zh)	2000-08-23
SA98190435A (ar)	2005-12-03
AU7927498A (en)	1999-03-01
GT199800114A (es)	2000-01-18
PA8456601A1 (es)	2000-05-24
EP1003744B1 (en)	2005-06-01
KR20010022583A (ko)	2001-03-26
JP2001512729A (ja)	2001-08-28
PE106199A1 (es)	1999-11-02
AP9801312A0 (en)	2000-01-30
TR200000333T2 (tr)	2000-05-22
EA200000098A1 (ru)	2000-08-28
ATE296825T1 (de)	2005-06-15

Publication	Publication Date	Title
NO996178D0 (no)	1999-12-14	4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
NO962412L (no)	1996-12-10	Pyrimidindion-, pyrimidintrion-, triazindion-, tetrahydrokinazolindionderivater som 1-adrenergiske reseptorantagonister
TR199700334T1 (tr)	1997-08-21	Indolil nöropeptid y reseptör antagonistleri.
TR199801594A3 (tr)	1999-03-22	CCR-3 reseptör antagonistleri.
NO993586L (no)	1999-09-21	K-8 reseptor antagonister
DK0856001T3 (da)	2002-12-30	Pyrimidinderivater som 5-HT2C-receptor-antagonister
ATE240936T1 (de)	2003-06-15	1-amino-alkylcyclohexane als nmda-rezeptor- antagonisten
NO985225L (no)	1998-11-09	Indolderivater nyttige som endotelinreseptorantagonister
DE69921351D1 (de)	2004-11-25	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
DK1068202T3 (da)	2009-03-16	1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
AU9185598A (en)	1999-04-12	Novel neuropeptide y receptor antagonists
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
DK1027342T3 (da)	2004-09-13	Cyclopentenderivater som motilinreceptorantagonister
TR199501389A2 (tr)	1996-07-21	Adesyon reseptörü antagonistleri (karsitlari).
DE50008020D1 (de)	2004-11-04	Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten
FI951798A0 (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO972612D0 (no)	1997-06-06	Pyridazoner som endotelinreseptorantagonister
NO20002575D0 (no)	2000-05-19	Substituerte oksimer som neurokininantagonister
AU7580998A (en)	1998-12-11	3-arylpropylamino neuropeptide y receptor antagonists
ID22978A (id)	1999-12-23	Antagonis reseptor endotelin
ATE310732T1 (de)	2005-12-15	7-phenyl-1,4-diazepanderivate als neurokininrezeptorantagonisten
DE69815072D1 (de)	2003-07-03	Substituierte 2,4-diaminopyrimidine
TR199601082A3 (tr)	1999-10-21	Entegrin reseptör antagonistleri.

Legal Events

Date	Code	Title	Description
2002-04-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application